SunOpta’s Refresco sale is closer now, but the real closing risk has not fully disappeared

SunOpta Inc. (NASDAQ: STKL) (TSX: SOY) has cleared a key regulatory hurdle in its proposed sale to an affiliate of Refresco Holding B.V., with the company announcing early termination of the Hart-Scott-Rodino waiting period tied to the $6.50-per-share cash transaction on April 10. The clearance matters because it removes one of the most visible antitrust conditions in a deal that was announced on February 6 and valued SunOpta at about $1.1 billion on an enterprise value basis. For investors, the signal is straightforward: the transaction now looks more executable than it did a week ago, even though it is not yet fully de-risked. SunOpta shares were trading at about $6.48 on April 11, with a 52-week range of $3.32 to $6.94, suggesting the market is pricing the company largely as a live merger spread rather than a standalone growth story at this stage.

The immediate significance of the HSR milestone is not that it guarantees closing. It does not. What it does is strip away one of the most disruptive risks in cross-border consumer and food supply-chain transactions: an extended U.S. antitrust review that can slow financing, unsettle customers, and widen the arbitrage spread. SunOpta said the early termination satisfies one closing condition, but the arrangement still requires remaining regulatory clearance or approval, approval by SunOpta shareholders, approval from the Ontario Superior Court of Justice, and the satisfaction or waiver of other customary conditions. That means the market should read this as progress, not as a victory lap.

Why does SunOpta’s HSR clearance matter so much for Refresco’s takeover timeline and deal certainty now?

The reason this approval matters is that merger risk is rarely linear. One unresolved antitrust issue can hold the entire transaction hostage, even when every other stakeholder is ready to move. By taking the U.S. antitrust waiting-period issue off the table early, SunOpta and Refresco reduce the odds that the deal drifts beyond the second quarter of 2026 target they set when the transaction was announced. In merger terms, the difference between “possible” and “probable” is often just a handful of closing conditions. HSR clearance moves this deal materially closer to the second category.

It also helps explain why SunOpta’s share price is sitting almost on top of the $6.50 cash consideration. A stock trading at $6.48 against a signed $6.50 offer is the market’s dry, unemotional way of saying that investors now assign a high probability to completion, while still reserving a sliver of discount for timing, paperwork, and the small but never-zero risk of a failed vote or delayed final court order. The 5-day share move of about negative 0.15% and 1-month gain of about 0.47% reinforce that point: this is no longer trading like a volatile operating story, but like a transaction nearing the administrative finish line.

What approvals still stand between SunOpta Inc. and the closing of the Refresco acquisition?

The next major checkpoint is the special shareholder meeting scheduled for April 16, 2026. SunOpta has already mailed its circular and proxy materials, and the board has unanimously recommended that voting shareholders approve the arrangement. The Ontario court had already granted an interim order on March 16 authorizing matters related to the arrangement process, including the meeting and the mailing of proxy materials. That procedural groundwork matters because it shows the deal machinery is already well advanced.

Still, two things remain particularly important. First, shareholder approval is usually straightforward in a board-supported all-cash deal with a meaningful premium, but it is never automatic. Second, the final court order remains a formal legal necessity under the Canada Business Corporations Act arrangement structure. Those remaining steps are less dramatic than an antitrust showdown, but they are the last doors that still need to open. In M&A, paperwork is often less glamorous than strategy, but it is where plenty of otherwise healthy deals go to die quietly.

Why would Refresco want SunOpta now as North American beverage outsourcing gets more strategic?

Strategically, the acquisition makes sense because Refresco is not buying a ticker symbol. It is buying manufacturing position, customer relationships, category adjacency, and a stronger North American footprint at a moment when private-label and outsourced beverage production remain structurally important. SunOpta brings exposure across beverages, broths, and better-for-you snacks, while Refresco has framed the combination as an expansion of its North American capabilities. That is not just polite deal language. It points to a manufacturing-and-customer-density play in a market where scale increasingly supports margins, procurement leverage, and network efficiency.

SunOpta’s strategic appeal also reflects timing. The board’s own circular said the company had been evaluating strategic alternatives and that management had engaged with third parties on transformational options well before Refresco’s approach. The same filing argued that the implied valuation, premium, and certainty of cash were better than the likely near- to medium-term value that shareholders could expect from remaining independent. In other words, SunOpta was not sold because the business lacked strategic relevance. It was sold because the board concluded that the market might not fully pay for that relevance quickly enough on a standalone basis.

Does SunOpta’s current stock price suggest investors now see the Refresco deal as highly likely to close?

Yes, broadly. When a target stock trades within pennies of a fixed cash offer, the spread becomes a live scorecard of perceived residual risk. SunOpta at roughly $6.48 versus a $6.50 cash offer implies investors see a very high closing probability, but not absolute certainty. The small discount captures the time value of money, procedural uncertainty, and the fact that until cash lands in accounts, a merger is still a proposal wearing a suit, not a settled fact.

That market behavior also helps frame sentiment more intelligently than dramatic headlines can. SunOpta’s stock is up sharply over three months, while remaining just below its 52-week high. That pattern fits a company whose valuation has been reset by a take-private bid rather than by a sudden re-rating of operating fundamentals alone. The average analyst target of about $7.40 on MarketWatch sits above the offer price, but in a signed cash transaction that figure becomes less important than closability, because upside is capped unless a rival bidder appears. Right now, nothing in the public record suggests a competing bid has emerged.

What does the SunOpta buyout process reveal about valuation discipline in food and beverage M&A?

One of the more interesting signals here is valuation discipline. SunOpta’s proxy materials described the $6.50-per-share offer as representing a 44% premium to the 20-trading-day volume-weighted average price as of February 5, 2026, with an enterprise value of about $1.1 billion and acquisition multiples of about 12.0x based on then-available adjusted EBITDA guidance for fiscal 2025 and about 10.8x based on projected adjusted EBITDA for fiscal 2026. Those numbers are not giveaway pricing, but neither do they suggest a market willing to indulge fantasy multiples for better-for-you and plant-based adjacent assets in 2026.

That matters beyond SunOpta. It suggests buyers still want assets with relevance to outsourced manufacturing, private label, and health-oriented categories, but they want those assets at valuations tied to execution and cash generation rather than category buzzwords. The era when “plant-based exposure” alone could stretch valuation assumptions appears long gone. What Refresco seems to be paying for is platform fit, not narrative heat. That is a healthier signal for the sector, even if it is less exciting for anyone hoping every branded or ingredient-adjacent food company can float away on optimism.

What could still go wrong in the SunOpta and Refresco transaction even after antitrust clearance?

The honest answer is not much, but not nothing. The biggest remaining risks are procedural delay, an unexpected vote complication, or some closing-condition dispute that emerges late in the process. SunOpta’s own materials also flagged financing availability, litigation, business disruption during deal pendency, and the possibility that the final order from the Ontario court is not obtained on the expected timeline. None of those risks currently look dominant, but merger history is full of deals that were considered “basically done” until they suddenly were not.

There is also a subtler operating risk. Signed deals can create strategic paralysis. Employees start thinking about integration. Customers seek reassurance. Competitors circle. Management attention gets divided between running the business and completing the transaction. For a company like SunOpta, which operates in supply-chain-heavy categories where customer continuity matters, even a short period of uncertainty can have commercial consequences. That is another reason the shrinking regulatory overhang is so valuable. The faster this closes, the less room there is for deal fatigue to become operational drag.

What are the most important strategic takeaways from SunOpta’s Refresco buyout approval milestone?

• The early termination of the HSR waiting period materially improves execution confidence for the Refresco acquisition, even though it does not complete the deal on its own.
• SunOpta’s stock trading at about $6.48 versus the $6.50 cash offer shows the market is pricing the company primarily as a merger spread rather than as a standalone rerating story.
• Remaining hurdles are now concentrated in shareholder approval, final Ontario court approval, and other customary closing conditions, not in a prolonged U.S. antitrust fight.
• The shareholder meeting on April 16, 2026 is the next major formal checkpoint investors should watch.
• Refresco’s interest in SunOpta underscores that North American beverage and food manufacturing scale remains strategically valuable in a cost-sensitive, outsourcing-heavy market.
• The board’s recommendation suggests SunOpta concluded certainty of value now was more attractive than waiting for the public market to fully reward its long-term standalone plan.
• The transaction valuation signals disciplined food-and-beverage M&A, where buyers still pay premiums for strategic fit but remain anchored to EBITDA logic.
• For peers, the message is that platform relevance still attracts buyers, but story stocks without operating leverage may not get the same reception.
• For merger arbitrage investors, the spread now looks narrow enough that the upside is limited unless an unexpected rival bidder appears.
• For executives across the sector, the bigger lesson is that regulatory friction matters, but deal credibility increasingly rests on valuation realism and strategic fit, not on category fashion.